Pyrazinamide resistance in multidrug-resistant tuberculosis in Aegean region, Turkey Source: Annual Congress 2008 - Epidemiology and clinical management of multidrug-resistant and extensively drug-resistant tuberculosis Year: 2008
Prevalence and characteristic of drug-resistant tuberculosis patients in South Halmahera District, eastern Indonesia Source: Virtual Congress 2020 – Tuberculosis and adverse events in different populations Year: 2020
Study of drug resistance among untreated new cases of tuberculosis in Oran, Algeria Source: Annual Congress 2008 - Infectious lung diseases including tuberculosis Year: 2008
Multi-drug resistance tuberculosis in Greece Source: Eur Respir J 2003; 22: Suppl. 45, 344s Year: 2003
Resistance of Mycobacterium tuberculosis to the first-line (MDR) and second line (XDR) anti tuberculosis drugs in the south western zone of Nigeria: A- 3 year retrospective study Source: Annual Congress 2010 - Tuberculosis drug resistance Year: 2010
Multidrug-resistant tuberculosis in the western region of Algeria Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology II Year: 2012
Multidrug-resistance TB in Armenia Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis Year: 2008
Multidrug resistant tuberculosis (MDR – TB) treatment outcomes in Iran Source: Eur Respir J 2004; 24: Suppl. 48, 657s Year: 2004
Treatment outcome of multi-drug resistant tuberculosis in Varanasi, India Source: Eur Respir J 2002; 20: Suppl. 38, 615s Year: 2002
The Beijing genotype dominates the multidrug-resistant Mycobacterium tuberculosis population in North-West Russia Source: Virtual Congress 2021 – Immunological and molecular characterisation of tuberculosis disease and infection Year: 2021
Effect of pyrazinamide resistance on treatment results of multidrug-resistant tuberculosis cases in Aegean region, Turkey Source: Annual Congress 2008 - Epidemiology and clinical management of multidrug-resistant and extensively drug-resistant tuberculosis Year: 2008
Treatment of multidrug resistant tuberculosis in penitentiary system of Tomsk Oblast Source: Eur Respir J 2001; 18: Suppl. 33, 338s Year: 2001
Mutations in the of rpoB gene in multidrug resistance mycobacterium tuberculosis from North Lima, Peru Source: Eur Respir J 2003; 22: Suppl. 45, 159s Year: 2003
Multidrug-resistant tuberculosis in Eastern Europe: still on the increase? Source: Eur Respir J 2012; 39: 1290-1291 Year: 2012
Risk factors for drug-resistant tuberculosis in the north of Portugal Source: Annual Congress 2011 - Risk factors and treatment outcomes in multidrug- and extensively drug-resistant tuberculosis Year: 2011
Mycobacterium tuberculosis (TB) drug resistance in the sanitary area of Aviles, Asturias (Spain) Source: Annual Congress 2008 - Epidemiology and clinical management of multidrug-resistant and extensively drug-resistant tuberculosis Year: 2008
Prevalence of aminoglycoside resistance among different MDR tuberculosis cases in Ukraine Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013
Treatment outcome of multi-drug resistant tuberculosis in the Republic of Moldova Source: International Congress 2017 – TB: co-morbidities and outcome Year: 2017
Cost and cost-effectiveness of multidrug-resistant tuberculosis treatment in Estonia and Russia Source: Eur Respir J 2012; 40: 133-142 Year: 2012
Frequency of multi-drug resistant M.tuberculosis and HLA-class-2 gene associations in tuberculosis patients in the Republic of Tuva Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis I Year: 2008